Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 56 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review

Article in Neuropsychopharmacology Reports (October 2023)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases

Article in Iranian Journal of Pharmaceutical Research (August 2022)

Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments

Article in International Journal of Molecular Sciences (September 2021)